approval
saveTECVAYLI (TECLISTAMAB-CQYV) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalMar 5, 2026 · 214d ago
- approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalOct 2, 2025 · 368d ago
- approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalAug 19, 2025 · 412d ago
- approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalDec 2, 2024 · 672d ago
- approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalNov 22, 2024 · 682d ago
- approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalJul 2, 2024 · 825d ago
- approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalMay 28, 2024 · 860d ago
- approvalTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalNov 16, 2023 · 1054d ago
same company · ±60 days · 6
- approvaltalquetamab: TALVEY (TALQUETAMAB-TGVS) — FDA approvalFeb 20, 2024
- approvalamivantamab: RYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalMar 1, 2024
- approvalustekinumab: STELARA (USTEKINUMAB) — FDA approvalMar 18, 2024
- approvalerdafitinib: BALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024
- approvalerdafitinib: BALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024
- approvalerdafitinib: BALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024
comments(0)
5-min edit window · permanent after that